A CASE REPORT OF PERITONEAL MESOTHELIOMA - A RARE VARIANT
Abstract
Introduction Primary Peritoneal Mesothelioma is a rare entity with an incidence of about 1-
2 cases per million. It can occur in any age group, although the 50 to 69 year age group is the most
affected. It is an unusual neoplasm in the sense that it demonstrates a wide spectrum of biological
aggressiveness. The incidence has increased in the past two decades. Only 20 to 33 of all
mesotheliomas arise from the peritoneum itself, the pleura are the most common site of origin. Here
we present a rare case of primary peritoneal mesothelioma multicystic variant.Case presentation We
report a case of middle aged gentleman who presented to our hospital with abdominal distension and
pain. He had been having these complaints for two months and was variously diagnosed as
hydatidosis, peritoneal secondaries etc. On examination he was found to have multiple abdominal
hard lesions .Investigations clinched the diagnosis of malignant peritoneal mesothelioma .He was
started on chemotherapy and has shown symptomatic response Conclusion Malignant peritoneal
mesothelioma is a rare fatal disorder but recent advances in chemotherapy have altered its
prognosis. High index of suspicion is essential as histopathology alone helps in the diagnosis and
early initiation of treatment is crucial for survival
Full Text:
PDFReferences
Bridda A, Padoan I, Mencarelli R, et al. Peritoneal mesothelioma: a review. MedGenMed 2007;9:32.
Legha SS, Muggia FM. Pleural mesothelioma: clinical features and therapeutic implications. Ann
Intern Med 1977;87:613-21.
Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest
;77:321-43.
Sugarbaker PH, Acherman YI, Gonzalez-Moreno S, et al. Diagnosis and treatment of peritoneal
mesothelioma: The Washington Cancer Institute experience. Semin Oncol. 2002;29:51–61.
Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353
:1591–1603.
Barnetson RJ, Burnett RA, Downie I, Harper CM, Roberts F. Immunohistochemical analysis of
peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies
to estrogen and progesterone receptors are useful. Am J Clin Pathol. 2006;125:67–7
Ordonez NG. The diagnostic utility of immunohistochemistry and electron microscopy in
distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study. Mod
Pathol. 2006;19:34–48.
Lugaresi ML, Mattioli S, Pilotti V, Guernelli N. [Pulmonary metastasis of malignant peritoneal
mesothelioma. Review of the literature and a case report] Minerva Chir. 2000;55:357–361.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University